Emrg Mkts Index MSCI Ishares (EEM) 34.25 $EEM Watch for

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Emrg Mkts Index MSCI Ishares (EEM) 34.25 $EEM

Watch for iShares MSCI Emerging Markets Index Fund/United States to Potentially Pullback After Gaining 1.33% Yesterday
Comtex SmarTrend(R) - Wed Mar 30, 11:46AM CDT
iShares MSCI Emerging Markets Index Fund/United States (NYSE:EEM) traded in a range yesterday that spanned from a low of $34.36 to a high of $34.58. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $33.94 on volume of 26.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EEM: 34.25 (-0.03)

After Yesterday's Rally of 1.33% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Mar 30, 11:44AM CDT
iShares MSCI Emerging Markets Index Fund/United States (NYSE:EEM) traded in a range yesterday that spanned from a low of $34.36 to a high of $34.58. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $33.94 on volume of 26.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EEM: 34.25 (-0.03)

Dovish Fed Pushes Investors Back Into Emerging Markets
at The Street - Wed Mar 30, 7:00AM CDT
But risks still lurk beneath the surface; investors should watch the safety nets. 
EEM: 34.25 (-0.03)

SmarTrend Watching for Potential Rebound in Shares of iShares MSCI Emerging Markets Index Fund/United States After 1.60% Loss
Comtex SmarTrend(R) - Wed Mar 23, 11:50AM CDT
iShares MSCI Emerging Markets Index Fund/United States (NYSE:EEM) traded in a range yesterday that spanned from a low of $33.41 to a high of $33.74. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $33.79 on volume of 32.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EEM: 34.25 (-0.03)

The Best Sectors for Emerging Markets Exposure Now
at The Street - Wed Mar 23, 7:00AM CDT
Emerging markets are waking up to life again. What is the best way in?
EEM: 34.25 (-0.03), EWZ: 26.30 (-0.56)

6 Stocks Trading on Big Volume -- and What to Do With Them Now
at The Street - Mon Mar 21, 2:14PM CDT
Here's a technical look at how to trade some of the most active stocks on the market right now.
EEM: 34.25 (-0.03), USO: 9.70 (-0.03), VAL: 107.02 (+0.45), VRX: 26.30 (-0.77), TMO: 141.59 (+0.80), MAR: 71.18 (-0.37), SHW: 284.67 (+0.24), AFFX: 14.01 (+0.02), HOT: 83.43 (-0.23)

Four ETFs For Low Volatility Value Investors
at The Street - Wed Mar 16, 3:29PM CDT
There is a reason why value has overtaken growth this year.
FPE: 18.67 (+0.02), EEM: 34.25 (-0.03), EFAV: 66.44 (-0.49), EEMV: 51.37 (+0.09), IVE: 89.93 (-0.19), IVW: 115.89 (-0.32)

Bull Market's Not as Old as Many Think
at The Street - Mon Mar 14, 12:00PM CDT
Which means it still has some life left in it.
EEM: 34.25 (-0.03), UA: 84.83 (-0.81), HD: 133.43 (+0.01), FL: 64.50 (-1.24), DRI: 66.30 (-0.28)

Can Emerging Market ETFs Sustain the Rally?
Zacks Equity Research - Zacks Investment Research - Wed Mar 09, 12:31PM CST
Emerging market ETFs shot up lately; can it sustain the momentum?
EEM: 34.25 (-0.03), ACWI: 56.06 (-0.27), SPY: 205.52 (-0.50), EEMV: 51.37 (+0.09), VWO: 34.58 (-0.04), QEMM: 49.26 (-0.14), DEM: 34.83 (-0.15)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 8

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 2

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 5

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 5

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 2

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading

Top 5 Most Recently Viewed Articles

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement

Updated Category News Views 52

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement LenioBio, known for its innovative approaches to rapid protein expression, has announced an exciting collaboration with ReciBioPharm, aiming to boost vaccine production and efficiency through advanced technology. This partnership is set to play a vital role in enhancing the capabilities of protein...

Continue Reading
Trump and Cuban's Rivalry Heats Up Amid Tariff Controversy

Updated Category News Views 172

Trump and Cuban's Feud Intensifies Donald Trump recently directed a fierce critique at billionaire Mark Cuban, accusing him of being a "loser" and labeling him as a "weak and pathetic bully." This latest insult arises from a public dispute ignited by Cuban's criticisms regarding Trump's proposed tariff strategies. The Catalyst of the Conflict The discord took a public...

Continue Reading
Cascale Revamps Engagement Model to Enhance Manufacturer Input

Updated Category News Views 77

Cascale Unveils New Membership Engagement Model Cascale, known previously as the Sustainable Apparel Coalition, is implementing a revolutionary member engagement and governance model aimed at ensuring comprehensive participation across its platform. This initiative emphasizes the vital role of suppliers and manufacturers, thereby enhancing decision-making processes within...

Continue Reading
Cosmic Crisp® Joins Forces with Dunford® for Delicious Pastries

Updated Category News Views 283

Cosmic Crisp® Collaborates with Dunford® for New Dessert Launch Cosmic Crisp® is making waves in the dessert market with an exciting collaboration with Dunford®, a brand celebrated for its exquisite pastries. Let’s explore this innovative partnership that introduces unique experiences for dessert lovers. The Launch of a New Pastry Delight The partnership between...

Continue Reading
Silexion Therapeutics Engages Investors with Public Offering

Updated Category News Views 138

Silexion Therapeutics Engages Investors with Public Offering Silexion Therapeutics Corp (NASDAQ: SLXN) is a clinical-stage biotech company focused on developing groundbreaking RNA interference (RNAi) therapies aimed at treating KRAS-driven cancers. Recently, the company announced closing a public offering priced at $1.35 per share, allowing investors to acquire a total of...

Continue Reading